title: [Polycystic ovary syndrome II. Endocrinology and metabolism].
abstract: The polycystic ovary syndrome (PCOS) is diagnosed by the simultaneous presence of polycystic ovaries by ultrasound together with clinical and biochemical signs of hyperandrogenaemia. Recently, it has been shown that a majority of PCO patients exhibit metabolic abnormalities, i.e. android obesity, insulin resistance and dyslipidaemia, all of which dispose to "civilized" life-style diseases such as cardiovascular disease and non-insulin dependent diabetes. PCOS is therefore not merely a gynaecological curiosity, but an endocrinopathy with multisystem sequelae. The endocrinological and metabolic aspects of the disease are discussed.
authors.affiliation: Arhus Universitetshospital, Skejby Sygehus, gynaekologisk obstetrisk afdeling, og.
authors.forename: P G
authors.initials: PG
authors.lastname: Ovesen
authors.forename: N
authors.initials: N
authors.lastname: Møller
authors.forename: S
authors.initials: S
authors.lastname: Greisen
authors.forename: H J
authors.initials: HJ
authors.lastname: Ingerslev
mesh_terms: D003937:Diagnosis, Differential; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism; D006801:Humans; D017588:Hyperandrogenism / Q000209:etiology / Q000378:metabolism; D010907:Pituitary Hormones / Q000378:metabolism; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism*; D014463:Ultrasonography
chemical_list: D012739:Gonadal Steroid Hormones; D010907:Pituitary Hormones
vernacular_title: Polycystisk ovarie-syndrome II. Endokrinologi og metabolisme.